What Is Adagene Inc. (ADAG) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Adagene Inc.'s intrinsic value is estimated at $1.27, suggesting the stock is overvalued at its current price of $3.67. With 9 out of 9 models flagging downside (-65.4% average return), the market may be pricing in unsustainable growth. Model dispersion is worth noting: PWERM targets $3.42 (-6.9%), versus ML-RIV at $0.27 (-92.6%). This +85.7% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About ADAG?
9 of 13 models are currently active for ADAG. All 9 active models suggest the stock trades above fair value. The Bayesian DCF estimates ADAG's intrinsic value at $1.60, implying -56.5% downside from the current price. See which stocks rank higher →
How Does ADAG Rank in Biotechnology?
Among 76 Biotechnology stocks, ADAG ranks #16 by Quality of Company score. CirclFi's QOC score of 6.0/10 evaluates 32 fundamental signals. A score of 6.0 indicates above-average quality.
See all Most Undervalued Biotechnology Stocks →
Within the Biotechnology space, Adagene Inc. competes in an environment where pipeline depth and stage distribution often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.
Is ADAG a Value Trap?
CirclFi's Value Trap algorithm assigns ADAG a score of 52/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
9 of 13 models are active for Adagene Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, Adagene Inc. is rated at 6.0/10. This solid-tier score maintains reasonable quality metrics with some areas for improvement.
The gap between the most bullish and bearish model spans +85.7% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every ADAG valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across ADAG's 9 active models, average confidence is 25%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad